MX2007013866A - Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de uso de los mismos. - Google Patents
Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de uso de los mismos.Info
- Publication number
- MX2007013866A MX2007013866A MX2007013866A MX2007013866A MX2007013866A MX 2007013866 A MX2007013866 A MX 2007013866A MX 2007013866 A MX2007013866 A MX 2007013866A MX 2007013866 A MX2007013866 A MX 2007013866A MX 2007013866 A MX2007013866 A MX 2007013866A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- pharmaceutical compositions
- casein
- derived peptides
- casein derived
- Prior art date
Links
- 239000005018 casein Substances 0.000 title abstract 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 title abstract 3
- 235000021240 caseins Nutrition 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 abstract 2
- 244000144972 livestock Species 0.000 abstract 2
- 235000013336 milk Nutrition 0.000 abstract 2
- 239000008267 milk Substances 0.000 abstract 2
- 210000004080 milk Anatomy 0.000 abstract 2
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 239000000693 micelle Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000032696 parturition Effects 0.000 abstract 1
- 239000008174 sterile solution Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Marine Sciences & Fisheries (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67629205P | 2005-05-02 | 2005-05-02 | |
| US68869705P | 2005-06-09 | 2005-06-09 | |
| PCT/IL2006/000524 WO2006117784A2 (en) | 2005-05-02 | 2006-05-02 | Pharmaceutical compositions comprising casein derived peptides and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2007013866A true MX2007013866A (es) | 2008-04-07 |
Family
ID=37308387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2007013866A MX2007013866A (es) | 2005-05-02 | 2006-05-02 | Composiciones farmaceuticas que comprenden peptidos derivados de la caseina y metodos de uso de los mismos. |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US7968513B2 (enExample) |
| EP (1) | EP1890720B1 (enExample) |
| JP (1) | JP5247429B2 (enExample) |
| KR (2) | KR20130122979A (enExample) |
| CN (1) | CN106421749A (enExample) |
| AR (1) | AR059462A1 (enExample) |
| AU (1) | AU2006242842B2 (enExample) |
| BR (1) | BRPI0611301A2 (enExample) |
| CA (1) | CA2607155C (enExample) |
| CL (1) | CL2011000039A1 (enExample) |
| EA (1) | EA016039B1 (enExample) |
| ES (1) | ES2400511T3 (enExample) |
| IN (1) | IN2014DN10391A (enExample) |
| MX (1) | MX2007013866A (enExample) |
| NZ (1) | NZ563936A (enExample) |
| PL (1) | PL1890720T3 (enExample) |
| UY (1) | UY29515A1 (enExample) |
| WO (1) | WO2006117784A2 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY29515A1 (es) * | 2005-05-02 | 2007-11-30 | Mileutis Ltd | Composiciones farmaceuticas que constan de peptidos derivados de la caseina y métodos del uso de los mismos |
| JP5507555B2 (ja) * | 2008-06-30 | 2014-05-28 | チョ−エー・ファーム・カンパニー・リミテッド | 豚のαＳ１カゼイン遺伝子、そのプロモーター、及びその用途 |
| US8133916B1 (en) | 2009-03-10 | 2012-03-13 | Amelgo, LLC | Control of milk production and mammary involution |
| US20110017323A1 (en) * | 2009-07-22 | 2011-01-27 | Ewa Herbst | Method and apparatus for inline testing |
| CA2797658C (en) * | 2010-04-21 | 2021-06-08 | Mileutis Ltd. | Casein peptide for use in the treatment of uterine infections |
| FR2971423B1 (fr) * | 2011-02-15 | 2014-01-10 | Ceva Sante Animale | Composition veterinaire antiprolactinique destinee aux ruminants |
| ES2759980T3 (es) * | 2012-03-19 | 2020-05-12 | Mileutis Ltd | Péptidos para el manejo de la lactación |
| EP2810695A1 (en) * | 2013-06-06 | 2014-12-10 | Ceva Sante Animale | Compositions and Method for controlling infections in non-human mammals using acute phase proteins |
| NZ753824A (en) * | 2016-11-09 | 2022-08-26 | Charles Sturt Univ | Livestock supplement and use thereof |
| AU2017376402B2 (en) * | 2016-12-13 | 2021-10-28 | Dsm Ip Assets B.V. | PUFA salt formulations (I) |
| CN108017709B (zh) * | 2017-12-12 | 2020-04-10 | 浙江辉肽生命健康科技有限公司 | 一种生物活性多肽kepmigvnqela及其制备方法和应用 |
| US20230106635A1 (en) * | 2020-02-19 | 2023-04-06 | Perfect Day, Inc. | Hypoallergenic recombinant milk proteins and compositions comprising the same |
| EP4329790A1 (en) * | 2021-04-28 | 2024-03-06 | Mileutis Ltd. | Compositions and methods for modulating mammary disorders and conditions |
| CN120379680A (zh) * | 2022-11-17 | 2025-07-25 | 米勒尤迪斯公司 | 用于调节乳腺病症和病状的组合物和方法 |
| CN121358342A (zh) * | 2023-05-16 | 2026-01-16 | 米勒尤迪斯公司 | 提升的乳质 |
| WO2026159713A1 (en) * | 2025-01-23 | 2026-07-30 | Mileutis Ltd. | A method of increasing milk production |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3764670A (en) * | 1970-10-28 | 1973-10-09 | Ministry Of Agriculture | Polypeptidic anti-biotic substances derived from casein |
| FR2474829B1 (fr) * | 1980-02-01 | 1983-09-09 | Agronomique Inst Nat Rech | Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications |
| US5405756A (en) * | 1982-03-30 | 1995-04-11 | Meiji Seika Kaisha, Ltd. | Transparent acid drink containing acid-soluble casein phosphopeptide |
| US5015628A (en) * | 1986-06-12 | 1991-05-14 | The University Of Melbourne | Anticariogenic phosphopeptides |
| ES2149771T3 (es) * | 1991-04-19 | 2000-11-16 | Univ Melbourne | Produccion de fosfopeptidos a partir de la caseina. |
| US5227154A (en) * | 1991-08-22 | 1993-07-13 | The University Of Melbourne | Phosphopeptides for the treatment of dental calculus |
| KR0140248B1 (ko) * | 1995-03-23 | 1998-06-15 | 한상기 | 신규한 카제인 포스포펩티드, 그것을 포함하는 카제인 및 그 제조방법 |
| AUPO566297A0 (en) * | 1997-03-13 | 1997-04-10 | University Of Melbourne, The | Calcium phosphopeptide complexes |
| AUPP494798A0 (en) * | 1998-07-29 | 1998-08-20 | Pacific Biolink Pty Limited | Protective protein formulation |
| AU775999B2 (en) | 1999-08-24 | 2004-08-19 | Meiji Seika Pharma Co., Ltd. | Growth promoting compositions for mammals and method of promoting the growth of mammals by using the same |
| US6391849B1 (en) * | 1999-11-19 | 2002-05-21 | Agricultural Research Organization, The Volcani Center | Method and pharmaceutical composition for disrupting lactation in a mammary gland and for treating and preventing mastitis |
| IL134830A0 (en) * | 2000-03-01 | 2001-05-20 | Chay 13 Medical Res Group N V | Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them |
| US7666996B2 (en) * | 2000-03-01 | 2010-02-23 | Peptera Pharmaceuticals Ltd | Casein derived peptides and uses thereof |
| JPWO2002072629A1 (ja) * | 2001-03-09 | 2004-07-02 | 明治製菓株式会社 | 免疫増強剤 |
| KR20070007128A (ko) | 2004-03-01 | 2007-01-12 | 펩테라 파마슈티컬스 엘티디. | 카제인 파생 펩타이드들과 그의 치료적 사용들 |
| UY29515A1 (es) * | 2005-05-02 | 2007-11-30 | Mileutis Ltd | Composiciones farmaceuticas que constan de peptidos derivados de la caseina y métodos del uso de los mismos |
-
2006
- 2006-05-02 UY UY29515A patent/UY29515A1/es not_active Application Discontinuation
- 2006-05-02 WO PCT/IL2006/000524 patent/WO2006117784A2/en not_active Ceased
- 2006-05-02 NZ NZ563936A patent/NZ563936A/en unknown
- 2006-05-02 CN CN201610544021.9A patent/CN106421749A/zh active Pending
- 2006-05-02 ES ES06728320T patent/ES2400511T3/es not_active Expired - Lifetime
- 2006-05-02 IN IN10391DEN2014 patent/IN2014DN10391A/en unknown
- 2006-05-02 JP JP2008509574A patent/JP5247429B2/ja not_active Expired - Lifetime
- 2006-05-02 KR KR1020137025206A patent/KR20130122979A/ko not_active Ceased
- 2006-05-02 BR BRPI0611301-0A patent/BRPI0611301A2/pt not_active Application Discontinuation
- 2006-05-02 AU AU2006242842A patent/AU2006242842B2/en not_active Expired
- 2006-05-02 US US11/913,239 patent/US7968513B2/en active Active
- 2006-05-02 CA CA2607155A patent/CA2607155C/en not_active Expired - Lifetime
- 2006-05-02 KR KR1020077028185A patent/KR101340676B1/ko not_active Expired - Lifetime
- 2006-05-02 MX MX2007013866A patent/MX2007013866A/es active IP Right Grant
- 2006-05-02 EP EP06728320A patent/EP1890720B1/en not_active Expired - Lifetime
- 2006-05-02 PL PL06728320T patent/PL1890720T3/pl unknown
- 2006-05-02 EA EA200702401A patent/EA016039B1/ru not_active IP Right Cessation
- 2006-05-15 AR ARP060101766A patent/AR059462A1/es not_active Application Discontinuation
-
2011
- 2011-01-07 CL CL2011000039A patent/CL2011000039A1/es unknown
- 2011-05-13 US US13/107,331 patent/US8338363B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP5247429B2 (ja) | 2013-07-24 |
| EA200702401A1 (ru) | 2008-08-29 |
| WO2006117784A2 (en) | 2006-11-09 |
| IN2014DN10391A (enExample) | 2015-08-14 |
| BRPI0611301A2 (pt) | 2010-08-31 |
| US7968513B2 (en) | 2011-06-28 |
| EA016039B1 (ru) | 2012-01-30 |
| JP2008540399A (ja) | 2008-11-20 |
| CA2607155C (en) | 2016-09-13 |
| NZ563936A (en) | 2010-03-26 |
| CL2011000039A1 (es) | 2011-06-10 |
| CA2607155A1 (en) | 2006-11-09 |
| EP1890720A2 (en) | 2008-02-27 |
| WO2006117784A3 (en) | 2009-05-22 |
| US20090069218A1 (en) | 2009-03-12 |
| US8338363B2 (en) | 2012-12-25 |
| ES2400511T3 (es) | 2013-04-10 |
| US20110212886A1 (en) | 2011-09-01 |
| KR20080012933A (ko) | 2008-02-12 |
| EP1890720B1 (en) | 2013-01-09 |
| KR101340676B1 (ko) | 2013-12-18 |
| CN106421749A (zh) | 2017-02-22 |
| AU2006242842A1 (en) | 2006-11-09 |
| PL1890720T3 (pl) | 2013-06-28 |
| EP1890720A4 (en) | 2010-05-26 |
| AR059462A1 (es) | 2008-04-09 |
| AU2006242842B2 (en) | 2011-12-08 |
| KR20130122979A (ko) | 2013-11-11 |
| UY29515A1 (es) | 2007-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN10391A (enExample) | ||
| CN102550481A (zh) | 白山羊羔羊的饲养方法 | |
| EP2046943A4 (en) | MUTTERMILK ISOLATED MILKY ACID BACTERIA WITH PROBIOTIC ACTIVITY AND HEMMETICITY AGAINST BODY WEAKNESS INCREASE | |
| MY148890A (en) | Novel bacteriophage and antibacterial composition comprising the same | |
| NZ594710A (en) | System and method for cleaning teats of a milk-producing animal utilising a hand-held applicator with scrubbing elements which disperses chlorine dioxide | |
| WO2005062878A3 (en) | Canine probiotic bifidobacteria globosum | |
| MX2013002949A (es) | Composiciones de acido abscisico para salud animal. | |
| RU2013153088A (ru) | Композиции, усиливающие вкусовую привлекательность | |
| EA201270779A1 (ru) | Новый вид корма для жвачных животных | |
| EP2689783A3 (en) | Growth control of oral and superficial microorganisms using gallium compounds | |
| EA201270220A1 (ru) | Молочная композиция, ее применение и продукты на ее основе, смесь для кормления млекопитающих и способ получения такой молочной композиции | |
| ZA201008588B (en) | Process for producing acidulated 50% concentrated solution and dry powder of peptides from protein products and waste of animal, fish and aquaculture origin | |
| PL2219437T5 (pl) | Urządzenie do przetrzymywania zwierząt mlecznych | |
| AR078388A1 (es) | Producto lacteo pasteurizado y fermentado, y procedimiento para su preparacion | |
| Kumar et al. | Existing calf rearing and milking management practices followed by dairy farmers in Uttarakhand | |
| ATE476104T1 (de) | Verwendung von 25-hydroxy-vitamin d3 zur verbesserung der vitalität von tieren | |
| RU2009101018A (ru) | Индукция толерантности к белкам яиц | |
| BR112015015611A2 (pt) | composições de iga secretora, métodos para a sua preparação e métodos para a sua utilização | |
| WO2011012240A3 (de) | Lipopeptide zur therapie und prophylaxe allergischer erkrankungen | |
| RU2008124216A (ru) | Способ лечения и профилактики фасциолеза коров | |
| WO2006132665A3 (en) | Biocides | |
| NZ590609A (en) | The use of sandalwood extracts and analogues as animal food additives | |
| MY169478A (en) | Nutritional composition for infants delivered via caesarean section | |
| RU2006114596A (ru) | Кормовая добавка для поросят-гипотрофиков с использованием стевии | |
| NO20070661L (no) | Anvendelsen av medisinske planter og ekstrakter derav for dyrs velvaere i veterinaer medisin og zooteknikk |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |